Clinical guidelines for the management of adult patients with atypical hemolytic-uremic syndrome; [Клинические рекомендации по ведению взрослых пациентов с атипичным гемолитико-уремическим синдромом]

Introduction. Atypical hemolytic-uremic syndrome (aHUS) is a systemic disease from the group of thrombotic microangiopathies with a progressive course and unfavorable prognosis, which is based on the uncontrolled activation of the alternative complement pathway of hereditary or acquired nature, leading to generalized thrombosis in the microvasculature. The goal is to provide current clinical guidelines for the care of adult patients with aHUS. Basic information. Experts from the National Association of Nephrologists have developed current clinical guidelines for the provision of medical care to adult patients with aHUS. The recommendations discuss in detail the issues of etiology, pathogenesis, epidemiology and clinical manifestations of the disease. Particular attention is paid to the diagnosis, differential diagnosis and treatment of aHUS, based on the principles of evidence-based medicine. © 2023 JSC Vidal Rus. All rights reserved.

Authors
Kozlovskaya N.L. , Dobronravov V.A. , Bobrova L.A. , Demyanova K.A. , Drapkina O.M. , Karunnaya A.V. , Kirsanova T.V. , Prokopenko E.I.
Publisher
Общеросийская общественная организация нефрологов Российское диализное общество
Issue number
4
Language
Russian
Pages
465-492
State
Published
Volume
25
Year
2023
Organizations
  • 1 A.K. Eramishantsev City Clinical Hospital, Nephrology Center for Pregnant Women with Kidney Disease, Moscow, Russian Federation
  • 2 A.K. Eramishancev City Clinical Hospital, 15, Lenskaya str., Moscow, 129327, Russian Federation
  • 3 V.S. Moiseev Department of Internal Medicine with the Course of Functional Diagnostics and Cardiology, RUDN University of Russia, 6, Miklukho-Maklaya str., Moscow, 117198, Russian Federation
  • 4 Academician I.P. Pavlov First St Petersburg State Medical University, Research Institute of Nephrology, Department of Propaedeutics of Internal Diseases, 6-8, L'va Tolstogo str., Saint Petersburg, 197022, Russian Federation
  • 5 I.M. Sechenov First Moscow State Medical University (Sechenov University), Department of Internal, Occupational Diseases and Rheumatology, Institute of Clinical Medicine, 8-2, Trubetskaya str., Moscow, 119991, Russian Federation
  • 6 National Medical Research Center for Therapy and Preventive Medicine of the Russian Ministry of Health, 10, Petroverigsky per., build. 3, Moscow, 101990, Russian Federation
  • 7 National Medical Research Center for Obstetrics, Gynecology and Perinatology, Department of Reproductive Hematology and Clinical Hemostasiology, 4, Oparina street, Moscow, 117997, Russian Federation
  • 8 M.F. Vladimirsky Moscow Regional Research Clinical Institute, Department of Transplantology, Nephrology and Artificial Organs, 61/2, Shchepkina str., build. 1, Моscow, 129110, Russian Federation
Keywords
atypical hemolytic-uremic syndrome; chronic kidney disease; complement system; eculizumab; molecular genetic study; thrombotic microangiopathy
Share

Other records

Amadori D., Andreianov B., Di Francesco M., Fagioli S., Girard T., Goatin P., Markowich P., Pietschmann J.-F., Rosini M.D., Russo G., Stivaletta G., Wolfram M.T.
Modeling and Simulation in Science, Engineering and Technology. Vol. Part F1951. 2023. P.. 9-53